BMPR1a Is Required for the Optimal TGFß1-Dependent CD207+ Langerhans Cell Differentiation and Limits Skin Inflammation through CD11c+ Cells. (2022)
Attributed to:
Oral Barrier Immuno-Surviellance; alterations across the life-course
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2022.02.014
PubMed Identifier: 35300973
Publication URI: http://europepmc.org/abstract/MED/35300973
Type: Journal Article/Review
Volume: 142
Parent Publication: The Journal of investigative dermatology
Issue: 9
ISSN: 0022-202X